- Investing Ideas
- /
- Belgian Pharmaceuticals & Biotech Leverage Leaders
Belgian Pharmaceuticals & Biotech Leverage Leaders
Results
3
0 new
3 companies
Financière de Tubize
Market Cap: €9.4b
Operates as a mono holding company whose sole investment is a stake in UCB which is a biopharma company in Belgium.
TUB
€211.00
7D
0.7%
1Y
44.3%
UCB
Market Cap: €44.5b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€234.20
7D
-0.9%
1Y
23.1%
argenx
Market Cap: €44.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€723.80
7D
1.1%
1Y
18.7%